Gemzar (gemcitabine)
Phase 3UNKNOWN 0 watching 0 views this weekπ Rising
77
Development Stage
β
Pre-clinicalβ
Phase 1β
Phase 24
Phase 35
ApprovedIndication / Disease
Cervical Cancer
Conditions
Cervical Cancer
Trial Timeline
Feb 1, 2009 β Jan 1, 2013
NCT ID
NCT00842660About Gemzar (gemcitabine)
Gemzar (gemcitabine) is a phase 3 stage product being developed by Eli Lilly for Cervical Cancer. The current trial status is unknown. This product is registered under clinical trial identifier NCT00842660. Target conditions include Cervical Cancer.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00842660 | Phase 3 | UNKNOWN |
Competing Products
20 competing products in Cervical Cancer